Company news

Organogenesis Holdings Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

September 5, 2023

Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance

August 8, 2023

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

July 9, 2023

Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

May 9, 2023

Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors

April 26, 2023

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

April 9, 2023

Organogenesis Applauds Findings from the Office of Inspector General

March 26, 2023

Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

February 28, 2023

Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance

February 28, 2023

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023

February 8, 2023

Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference

December 4, 2022

Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results

November 8, 2022

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022

September 25, 2022

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 6, 2022

Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution

August 14, 2022

Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results

August 8, 2022

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022

June 29, 2022

Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results

May 9, 2022

Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors

May 4, 2022

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference

April 4, 2022

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

April 4, 2022

Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal

March 16, 2022

Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference

March 7, 2022

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance

February 28, 2022

Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors

February 16, 2022

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February

February 10, 2022

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

February 6, 2022

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

November 21, 2021

Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results

November 8, 2021

Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference

November 7, 2021

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

October 26, 2021

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

October 6, 2021

Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results

August 8, 2021

Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank

August 8, 2021

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021

July 1, 2021

Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

May 9, 2021

Organogenesis Appoints Jon Giacomin to Board of Directors

May 9, 2021

CORRECTING and REPLACING – Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

May 9, 2021

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting

May 5, 2021

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021

April 11, 2021

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

March 15, 2021

Organogenesis Appoints David C. Francisco as Chief Financial Officer

February 15, 2021

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March

February 8, 2021

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021

February 7, 2021

Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis

January 13, 2021

Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020

January 12, 2021

Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee

January 10, 2021

Organogenesis Holdings Inc. to Participate in the ICR Conference 2021

January 4, 2021

Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock

November 12, 2020

Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock

November 9, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 13 decks. Every deck is listed under its year.